BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9069103)

  • 1. Beta-2-microglobulin, neopterin and monocyte Fc gamma receptors in opportunistic infections of HIV-positive patients.
    Dunne J; Feighery C; Whelan A
    Br J Biomed Sci; 1996 Dec; 53(4):263-9. PubMed ID: 9069103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].
    Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A
    Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum neopterin and beta2-microglobulin concentration as "prognostic markers" of AIDS].
    Halota W; Jaruga B; Pawłowska M
    Pol Merkur Lekarski; 2002 Aug; 13(74):126-8. PubMed ID: 12420343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of circulating receptor Fc gamma RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta.
    Allen JB; Wong HL; Guyre PM; Simon GL; Wahl SM
    J Clin Invest; 1991 May; 87(5):1773-9. PubMed ID: 1708784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
    Mildvan D; Spritzler J; Grossberg SE; Fahey JL; Johnston DM; Schock BR; Kagan J
    Clin Infect Dis; 2005 Mar; 40(6):853-8. PubMed ID: 15736019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behaviour of different clinical, immunological and serological parameters observed in a group of HIV positive patients during a 12 month treatment period with zidovudine.
    Crocchiolo PR; Lizioli A; Arcidiacono I; Cantaluppi P; Filippi C; Sobatti D; Bedarida G; D'Agostino F; Cambie G; Nardella ML
    Boll Ist Sieroter Milan; 1990 Jun; 69(2):423-30. PubMed ID: 1983798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A decade of research on the natural history of HIV infection: Part 1. Markers.
    Strathdee SA; O'Shaughnessy MV; Montaner JS; Schechter MT
    Clin Invest Med; 1996 Apr; 19(2):111-20. PubMed ID: 8697670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between neopterin and beta-2-microglobulin levels and HIV status in Romanian orphanage children.
    Zaknun D; DiFranco M; Oswald HP; Zaknun J; Mayersbach P; Vuja E; Wachter H; Fuchs D
    Wien Klin Wochenschr; 1993; 105(10):284-8. PubMed ID: 8517058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum neopterin and serum beta 2-microglobulin in subjects with lung infections.
    Carstens J; Andersen PL
    Eur Respir J; 1994 Jul; 7(7):1233-8. PubMed ID: 7925900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum adenosine deaminase in human immunodeficiency virus infection. Its relationship with CD4+ lymphocytes and beta 2-microglobulin].
    Iñigo MA; Ruiz López de Tejada M; Torres-Tortosa M; Sánchez-Porto A; Ugarte I; García de Lomas E; Morán Nestares A
    Med Clin (Barc); 1992 Dec; 99(20):766-8. PubMed ID: 1361013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mononuclear cell activation in Crohn's disease. Evaluation using serum assay of neopterin and interleukin-2 soluble receptors].
    Duclos B; Reimund JM; Lang JM; Coumaros G; Chamouard P; Lehr L; Baumann R; Koehl C; Weill JP
    Gastroenterol Clin Biol; 1990; 14(1):22-7. PubMed ID: 2311849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA class I soluble antigen serum levels in HIV-positive subjects--correlation with cellular and serological parameters.
    Puppo F; Orlandini A; Ruzzenenti R; Comuzio S; Salamito A; Farinelli A; Stagnaro R; Indiveri F
    Cancer Detect Prev; 1990; 14(3):321-3. PubMed ID: 2117484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum nitrite plus nitrate in infection with human immunodeficiency virus type-1.
    Zangerle R; Fuchs D; Reibnegger G; Werner-Felmayer G; Gallati H; Wachter H; Werner ER
    Immunobiology; 1995 Jun; 193(1):59-70. PubMed ID: 7590863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M; Keane N; McKinnon E; Phung S; Price P
    HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on serum neopterin concentration in hemophiliacs with anti-human immunodeficiency-virus type I antibody].
    Matsuda J
    Rinsho Byori; 1991 Jul; 39(7):743-7. PubMed ID: 1920867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection.
    Look MP; Rockstroh JK; Rao GS; Kreuzer KA; Spengler U; Sauerbruch T
    Biol Trace Elem Res; 1997 Jan; 56(1):31-41. PubMed ID: 9152510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.
    Whittle H; Egboga A; Todd J; Corrah T; Wilkins A; Demba E; Morgan G; Rolfe M; Berry N; Tedder R
    AIDS; 1992 Jul; 6(7):685-9. PubMed ID: 1354448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Dis Markers; 1990; 8(3):164-5. PubMed ID: 2125538
    [No Abstract]   [Full Text] [Related]  

  • 19. Behaviour of several 'progression markers' during the HIV-Ab seroconversion period. Comparison with later stages.
    Cordiali Fei P; Massa A; Prignano G; Pietravalle M; Alemanno L; Vitelli G; Palamara G; Giglio A; Gandolfo GM; Gentili G
    J Biol Regul Homeost Agents; 1992; 6(2):57-64. PubMed ID: 1384275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection.
    Aziz N; Nishanian P; Taylor JM; Mitsuyasu RT; Jacobson JM; Dezube BJ; Lederman MM; Detels R; Fahey JL
    J Infect Dis; 1999 Apr; 179(4):843-8. PubMed ID: 10068579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.